.jpg)
Search
- 1 day ago
- 4 min
Parallel Learning closes on $20 million to test, diagnose and empower special needs students
Our mission is to work hand-in-hand with school districts and families to deliver the highest quality developmental services.
- 6 days ago
- 1 min
Today’s climate for cross-border transactions and venture capital financing for medical devices
A MedTalks commentary by Jeffrey Friedland
- May 20
- 4 min
ApiJect raises $111 million to transform the fill, finish and delivery of injectable vaccines
ApiJect is developing a truly innovative technology, that could transform the manufacturing and delivery of life-saving injectable drugs.
- May 13
- 4 min
GE Healthcare agrees to invest up to $50 million in Israeli start-up Pulsenmore
This investment is aimed at accelerating global adoption of Pulsenmore’s homecare ultrasound solutions.
- May 8
- 8 min
Tubulis closes on $63 Million to advance its pipeline of uniquely assembled antibody drug conjugates
Tubulis’ capability of creating antibody-drug conjugates is based on a range of targeting molecules, novel payloads and technology.
- Apr 26
- 2 min
Fathom receives investment to drive innovation and performance of medical coding
Fathom is a medical coding automation platform, an AI solution that fuses the best of deep learning and Natural Language Processing
- Apr 25
- 3 min
Syllable Raises $40 Million to Improve the Patient Experience with Intelligent Voice Solutions
Syllable is an AI-enabled healthcare services company that transforms the way health systems provide access to care.
- Apr 23
- 3 min
With an additional $16 million, 9am.health will advance its care for people living with diabetes
Innovative virtual care provider is now available in 47 states and D.C. directly to consumers, providing personalized treatment plans to...
- Apr 16
- 2 min
Koelis closes $10.8 million financing for image-guided prostate cancer interventions
Koelis is a leader in the market for image-guided prostate cancer interventions including biopsy diagnosis and minimally invasive s
- Apr 15
- 4 min
With new funding, Pictor partners with Mobility Health for a SARS-CoV-2 antibody test
“The PictArray™ SARS-CoV-2 Antibody Test is a high performance, all-in-one, NP/SP COVID-19 antibody test with serological differentiation.
- Apr 13
- 3 min
Surf Bio Wraps up $16 Million Seed Financing to Advance Breakthrough Drug Stabilization Technology
Surf Bio is a preclinical biopharmaceutical company leveraging a novel biotechnology platform to develop enhanced therapeutic solutions,,,
- Apr 12
- 3 min
Daewoong Pharmaceutical and HanAll Biopharma Invest in Turn Biotechnologies for mRNA Medicines
Turn Bio is a pre-clinical-stage biopharmaceutical company focused on cellular repair via epigenetic reprogramming of cells.
- Apr 10
- 3 min
VASC Srl closes on $1.96 millon to launch VELEX for the treatment of Chronic Venous Insufficiency
We are now on the verge of bringing VELEX™ into the market and provide proof of the validity of our EVA (Empty Vein Ablation) procedure.
- Apr 9
- 4 min
Doceree raises $11 Million for a network of physician-only platforms for programmatic messaging
Doceree is transforming the way digital interactions between pharmaceutical brands and prescribers are facilitated.
- Apr 7
- 2 min
ENDOVASCULAR ENGINEERING CLOSES ON $15 MILLION FOR VENOUS THROMBECTOMY SOLUTIONS
"With the close of this funding we will continue the journey from concept to clinical use/"
- Mar 26
- 3 min
Geneos Therapeutics closes on $17 million to advance its personalized cancer immunotherapy platform
Globally, liver cancers are the fourth most common cause of cancer-related death and ranked sixth in terms of annual incidence.
- Mar 21
- 3 min
Triumvia Immunologics completes $100 million round for its T cell therapeutics
“Cell therapies have become an essential modality in the oncology therapeutic arsenal and a priority for many biopharma companies.
- Mar 18
- 2 min
MedTex Ventures raises $46.5 million to invest in early-stage medical devices
MedTex Ventures has partnered with Biotex Inc. to help source, analyze, develop, finance and manage medical device companies.
- Mar 13
- 5 min
HTL Biotechnology makes strategic investment in GelMedix, for ocular and regenerative therapies
GelMEDIX's most advanced program is focused on developing a sustained release corticosteroid subconjunctival implant.
- Mar 12
- 2 min
LumiThera obtains $5.5 million to support its macular degeneration product line
Products are a diagnostic and monitoring system that measures the electrical activity of the retina in response to a light stimulus.